The two-day event, organized by KACST, in cooperation with the Global Thomson Reuters Corporation, is discussing how to make full use of the corporation’s new resources, state analysis-tools of toxic and biological tracks and interactions besides known diseases, in addition to an integrated database of biological, chemical and pharmaceutical information.Two experts from the corporation — Dr. Kyle White and Dr. Bill Baiona — addressed the opening day’s session in the presence of several prominent figures, including experts and researchers from within the Kingdom and abroad. They spoke at length about Thomson’s information bases of MetaCore, MetaDrug and Integrity as well as their relevance and reliability. They also cited examples of the way of carrying out research through these platforms.Thomson Reuters Integrity provides researchers with reliable, detailed information across multiple disciplines and from the perspective of a scientist — to support successful drug research and development while its MetaCore delivers high quality biological systems content in context, giving essential data and analytical tools to accelerate scientific research. As for MetaDrug, it provides temporary use of non-downloadable software for use in data mining, and scientific research and analysis in the field of molecular biology, systems biology, chemoinformatics and bioinformatics.In their presentation, White and Baiona gave a detailed description of the corporation’s other databases, especially Thomson Pharma and Thomson Newport, and their crucial role in scientific research in the best possible manner. Thomson Pharma helps to explore the best pharmaceutical content from the extensive collection of scientific, healthcare and financial information databases offered by Thomson Reuters.Their presentations also shed light on integrated medicine discoveries, under-developing medicines, the latest drugs and compounds in addition to the genetic sequence and its objectives, clinical experiments, in addition to reviewing patents, scientific journals, conferences and relevant academic articles.Thomson Reuters Corporation, founded in 2008, is considered the main global source of smart information for companies and professionals due to combining expertise and innovative technology industry to provide decision makers in fields of financial, tax and legal accounting, health care, science, markets and media with the vital information they seek.
